Follow-The-Filings

Security · featured owners

GILD Gilead Sciences Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 6 Owners
  • #235
  • Max 1.6%
  • Master 0.18%
  • $3B
  • 3 reduce

GILD (Gilead Sciences Inc.) is held in 6 featured 13F books as of 2026 Q2. Dodge & Cox is the largest tracked holder by portfolio weight (1.6%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.6% (Dodge & Cox) · not free-float ownership

  1. Dodge & Cox reduce 1.6%
  2. David Witzke 0.40%
  3. John Rogers reduce 0.25%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Dodge & Cox 2026 Q2 1.6% Reduce −2.4% 23,677,567 $3B history
John Rogers - Ariel Investments 2026 Q2 0.25% Reduce −3.3% 195,657 $25M history
David Witzke - Avidity Partners Management 2026 Q2 0.40% Hold 20,000 $3M history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 <0.01% Reduce −40.0% 18,000 $2M history
Mairs & Power 2026 Q2 <0.01% Hold 2,275 $287K history
Kentucky Trust Co. - Kentucky Trust 2026 Q2 <0.01% Hold 10 $1K history

6 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 14 rows shown

Filed Form Detail Links
4 Period Sep 10, 2026 · 5 forms Filing Doc
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 26, 2026 Filing Doc
4 Period Aug 20, 2026 Filing Doc
4 Period Aug 17, 2026 · 2 forms Filing Doc
4 Period Aug 10, 2026 Filing Doc
4 Period Aug 3, 2026 Filing Doc
4 Period Jul 15, 2026 · 2 forms Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 15, 2026 · 2 forms Filing Doc
4 Period Jun 10, 2026 · 5 forms Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 26, 2026 Filing Doc
4 Period May 15, 2026 Filing Doc

Updated 3 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $27.12B $28.75B $29.44B
Gross profit * $20.62B $22.5B $23.21B
Gross margin * 76.0% 78.3% 78.8%
Net income $5.66B $0.48B $8.51B
Net margin * 20.9% 1.7% 28.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.08B $19.17B $18.34B
Total non-current assets * $46.04B $39.82B $40.68B
Total assets $62.12B $59B $59.02B
Total current liabilities $11.28B $12B $11.81B
Total equity $22.83B $19.33B $22.7B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $8.01B $10.83B $10.02B
Cash from investing -$2.26B -$3.45B -$4.79B
Cash from financing -$5.12B -$3.43B -$7.74B
Net change in cash $0.673B $3.91B -$2.43B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders